An exploratory clinical trial on the efficacy and safety of glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes on maintenance hemodialysis.
- Resource Type
- Article
- Source
- Renal Replacement Therapy; 6/11/2022, Vol. 8 Issue 1, p1-10, 10p
- Subject
- Language
- ISSN
- 20591381